Jay Varughese, M.D.

“The ability to continually improve and innovate inpatient cancer care motivates me every day.”
Devoted to compassionate care, Jay Varughese, M.D., became a hospital-based physician specializing in hematology and oncology to provide comfort and care during one of the most vulnerable times of a cancer patient’s journey.
At City of Hope, Dr. Varughese appreciates the opportunity to innovate and focus exclusively on hospital-based cancer care. He believes that everything starts and ends with effective, patient-centric communication. His practice and interests involve using multiple modalities to support cancer patient symptom control with a focus on quality of life.
- Board certified in Internal Medicine
- 2003, M.D, Ross University School of Medicine
- 1997, B.S, University of California San Diego
- 2003-2006, Internal Medicine, Newark Beth Israel Medicine Center
- 2006-2009, Hematology and Oncology, Newark Beth Israel Medical Center
- 2022-present, Clinical Professor and Chief, Division of Hospital Medicine, Department of Medicine, City of Hope, Duarte, California
- 2016-2022, Hospital Medicine Director of Inpatient Oncology, University of California San Diego, La Jolla, California
- 2013-2016, Hospitalist, University of California San Diego, La Jolla, California
- 2010-2013, Co-Director Nocturnist services, University of California San Diego, La Jolla, California
- 2009-2010, Nocturnist, University of California San Diego, La Jolla, California
- 2022 and 2014, MED 401 Excellence in Teaching Award, University of California San Diego School of Medicine
- 2018, University of California San Diego, Health Leadership Academy
- 2017 and 2012, University of California San Diego Division of Hospital Medicine MVP Award
- 2004, PGY-1 Intern of the Year, Newark Beth Israel Medical Center
- 2011-present, Society of Hospital Medicine
- 2009-present, California Medical Association
▪ Ally M, McIntyre J, Thota S, Kviatkovsky M, Chace C, Varughese J, Quartarolo J, Montazeri M, Choueiri M, Horman S. Fostering Togetherness Amidst A Pandemic: Creating A Peer Support Network. Poster Presentation at the Society of Hospital Medicine, March 2021
▪ Varughese J. Vision Loss As Initial Presentation Of Lung Cancer
Poster Presentation at the Society of Hospital Medicine, May 2019
▪ Varughese J, Clay B, El-Kareh R. How Sweet it is…Reducing Duplicate Hemoglobin A1C
Poster Presentation at the Society of Hospital Medicine, May 2017
▪ Varughese J, Hussain F. Inpatient Diagnosis of Primary Membranous Nephropathy and Cardiac Amyloidosis Poster Presentation at the Society of Hospital Medicine, May 2017
▪ Toledo J, Hsiao G, Varughese J. Use of a Best Practice Alert to Curb Inappropriate Duplicate Pneumococcal Vaccinations Poster Presentation at the American Society of Health-System Pharmacists, May 2014
▪ Varughese J, Toledo J, Hsiao G, Seymann G. Too Much Of a Good Thing: The Prevalence and Cost of Duplicate Pneumococcal Immunizations Poster Presentation at the Society of Hospital Medicine, May 2013
▪ Sebasky M, DeKorte M, Horman S, Varughese J, Seymann G. Night Vision: Resident and Hospitalist Perceptions of Night Shift Education Poster Presentation at the Society of Hospital Medicine, May 2013
▪ Varughese J, Jenkins I. Venous Thromboembolism Prophylaxis for Medical Patients Hospital Medicine Clinics April 2012;1(2) e238-e253
▪ Varughese J, Sandhu M, Sachdev S, Palekar P, Cohen A.J, Eisenberger A. Arteriovenous(AV) Fistula Thrombosis and Thrombophilia Poster Presentation/XXII Congress of the International Society of Thrombosis and Haemostasis, July 2009
▪ Varughese J, AJ. Cohen. Experience with epidural anaesthesia in pregnant women with von Willebrand disease. Haemophilia Nov 2007;13(6):730-3
▪ Sabnani I, Varughese J, Washer R, Youngworth H, Tsang P. Multiple synchronous unusual extranodal sites of relapse in a patient with mantle cell lymphoma Clinical Advances in Hematology and Oncology, 2007 Oct;5(10):797-8,802; discussion 802-3
▪ Varughese JI, Cohen SJ. Experience with Epidural Anesthesia in Pregnant Women with von Willebrand Disease Poster Presentation /46th American Society of Hematology Annual Meeting, December 2004
▪ Chan MF, Raju BG, Kois A, Varughese JI, Varughese KI, Balaji VN. Design and Synthesis of Peptidomimetic Endothelin Antagonists based on 1,4-Diazobicyclo[4.3.0], Nonane Framework”
Heterocycles Vol.51, pp.5-8, 1999